dc.contributor.author | Murphy, Emma J. | |
dc.contributor.author | Rezoagli, Emanuele | |
dc.contributor.author | Collins, Catherine | |
dc.contributor.author | Kumar Saha, Sushanta | |
dc.contributor.author | Major, Ian | |
dc.contributor.author | Murray, Patrick | |
dc.date.accessioned | 2023-07-11T11:01:57Z | |
dc.date.available | 2023-07-11T11:01:57Z | |
dc.date.copyright | 2023 | |
dc.date.issued | 2023-06-05 | |
dc.identifier.citation | Murphy, E. J., Rezoagli, E., Collins, C., Kumar Saha, S., Major, I. and Murray, P. (2023) Sustainable production and pharmaceutical applications of β-glucan from microbial sources, Microbiological Research, 274(127424), pp. 1-16. https://doi.org/10.3390/ pharmaceutics15010200 | en_US |
dc.identifier.issn | 0944-5013 | |
dc.identifier.uri | https://research.thea.ie/handle/20.500.12065/4564 | |
dc.description.abstract | β-glucans are a large class of complex polysaccharides found in abundant sources. Our dietary sources of β-glucans are cereals that include oats and barley, and non-cereal sources can consist of mushrooms, microalgae, bacteria, and seaweeds. There is substantial clinical interest in β-glucans; as they can be used for a variety of diseases including cancer and cardiovascular conditions. Suitable sources of β-glucans for biopharmaceutical applications include bacteria, microalgae, mycelium, and yeast. Environmental factors including culture medium can influence the biomass and ultimately β-glucan content. Therefore, cultivation conditions for the above organisms can be controlled for sustainable enhanced production of β-glucans. This review discusses the various sources of β-glucans and their cultivation conditions that may be optimised to exploit sustainable production. Finally, this article discusses the immune-modulatory potential of β-glucans from these sources. | en_US |
dc.format | application/pdf | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.ispartof | Microbiological Research | en_US |
dc.rights | Attribution 4.0 International | * |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | β-glucan | en_US |
dc.subject | Micro-algae | en_US |
dc.subject | Yeast | en_US |
dc.subject | Fungi | en_US |
dc.subject | Bacteria | en_US |
dc.subject | Immune-modulation | en_US |
dc.title | Sustainable production and pharmaceutical applications of β-glucan from microbial sources | en_US |
dc.type | info:eu-repo/semantics/article | en_US |
dc.contributor.affiliation | Technological University of the Shannon: Midlands Midwest | en_US |
dc.description.peerreview | yes | en_US |
dc.identifier.doi | https://doi.org/10.1016/j.micres.2023.127424 | en_US |
dc.identifier.endpage | 16 | en_US |
dc.identifier.orcid | https://orcid.org/0000-0002-5620-0058 View this author’s ORCID profile | en_US |
dc.identifier.orcid | https://orcid.org/0000-0002-4506-7212 | en_US |
dc.identifier.orcid | https://orcid.org/0000-0002-3981-8833 | en_US |
dc.identifier.orcid | https://orcid.org/0000-0002-0538-9786 | en_US |
dc.identifier.orcid | https://orcid.org/0000-0001-6349-7761 | en_US |
dc.identifier.startpage | 1 | en_US |
dc.identifier.volume | 274 | en_US |
dc.rights.accessrights | info:eu-repo/semantics/openAccess | en_US |
dc.subject.department | LIFE–Health and Biosciences Research Institute | en_US |
dc.type.version | info:eu-repo/semantics/publishedVersion | en_US |